Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1365837
Abstract: ABSTRACT Introduction: India accounts for 25% of the global burden of MDR-TB. In 2016, the India’s Revised National TB Control Programme reported a success rate of 46% among 19,298 MDR-TB patients treated under the programme.… read more here.
Keywords: developing therapies; mdr india; mdr; treatment ... See more keywords